Table 3.
Practice guideline 1: resected NSCLC stage II and IIIA patients
| Item |
Rating percent
A
|
Mean | Sd | Mode | ||
|---|---|---|---|---|---|---|
| Disagree | Neutral | Agree | ||||
|
Assessment of the Recommendations | ||||||
| a. Aware of the recommendations |
4.9 |
2.4 |
92.7 |
6.3 |
1.2 |
7.0 |
| b. Agree with the recommendations |
5.0 |
0 |
95.0 |
6.3 |
1.1 |
7.0 |
| c. Recommendations are unambiguous |
7.5 |
7.5 |
85.0 |
5.9 |
1.5 |
7.0 |
| d. Recommendations are supported by the evidence |
2.5 |
0 |
97.5 |
6.4 |
0.9 |
7.0 |
| e. Recommendations are current |
7.7 |
2.6 |
89.7 |
6.0 |
1.3 |
6.0 |
| f. Recommendations are easy to apply in their clinical context |
2.6 |
10.3 |
87.2 |
6.2 |
1.3 |
7.0 |
| g. Recommendations are too rigid for the patients they are intended |
68.4 |
10.5 |
21.1 |
2.9 |
1.8 |
2.0 |
| h. Recommendations do not align with how they typically manage these patients |
80.0 |
5.0 |
15.0 |
2.4 |
1.8 |
1.0a |
| i. Recommendations apply to the patients they target |
7.9 |
0 |
92.1 |
6.0 |
1.3 |
6.0 |
| j. Recommendations are biased |
82.9 |
9.8 |
7.3 |
2.0 |
1.6 |
1.0 |
| k. Support for the recommendations |
5.0 |
2.5 |
92.5 |
6.3 |
1.1 |
7.0 |
| l. Clinical practice of respondent aligns with the recommendations |
5.0 |
5.0 |
90.0 |
6.2 |
1.1 |
7.0 |
|
Assessment of the Evidentiary Base | ||||||
| a. It is complete |
7.7 |
5.1 |
87.2 |
6.0 |
1.2 |
7.0 |
| b. It is convincing |
2.6 |
5.1 |
92.3 |
6.1 |
1.0 |
7.0 |
| c. It is informative |
7.5 |
0 |
92.5 |
6.1 |
1.2 |
7.0 |
| d. It is relevant to typical patients |
12.5 |
2.5 |
85.0 |
6.0 |
1.6 |
7.0 |
| e. It is strong |
5.3 |
2.6 |
92.1 |
5.9 |
1.2 |
6.0 |
| f. It is current | 10.5 | 2.6 | 86.8 | 5.8 | 1.5 | 6.0a |
NSCLC, non-small cell lung cancer.
ADisagree (ratings 1 to 3 on 7-point scale); Neutral (rating 4 on 7-point scale); Agree (rating 5 to 7 on 7-point scale).
aMultiple mode exists. The smallest value is shown.